Metraipolis › archive › dc_9be442d9cee5

Metformin Downregulates the STAT Pathway and Reduces Bone Marrow Fibrosis in Primary Myelofibrosis Patients: Final Results of the Phase II FIBROMET Trial — Europe PMC PMID:41456173

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41456173
DOI
10.1002/hon.70163
License (as archived)
solo-consultazione
Archived
2026-11-07T04:39:01.441Z
SHA-256 of the archived text
33115e38a47c4be93097a2b57543d3856b3cf783e6394be69e0de1fd98417fc4
Stable URL of this page
https://metraipolis.com/documento/dc_9be442d9cee5

How to cite

Metformin Downregulates the STAT Pathway and Reduces Bone Marrow Fibrosis in Primary Myelofibrosis Patients: Final Results of the Phase II FIBROMET Trial — Europe PMC PMID:41456173 — Europe PMC (en), https://europepmc.org/article/MED/41456173 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9be442d9cee5 (Metraipolis archive dc_9be442d9cee5, sha256 33115e38a47c4be93097a2b57543d3856b3cf783e6394be69e0de1fd98417fc4)
BibTeX
@misc{dc9be442d9cee5,
  title = {Metformin Downregulates the STAT Pathway and Reduces Bone Marrow Fibrosis in Primary Myelofibrosis Patients: Final Results of the Phase II FIBROMET Trial — Europe PMC PMID:41456173},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41456173},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9be442d9cee5; sha256 33115e38a47c4be93097a2b57543d3856b3cf783e6394be69e0de1fd98417fc4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41456173. Agents can read the archived copy with the MCP tool read_document.